| 6501 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
54 |
| 6502 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
72 |
| 6503 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
54 |
| 6504 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
58 |
| 6505 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
63 |
| 6506 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
48 |
| 6507 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
62 |
| 6508 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
62 |
| 6509 |
Apheresis |
Autologous
|
Non-Hodgkin-Lymphoma-Relapse
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
51 |
| 6510 |
Apheresis |
Allogeneic
|
Other Malignancy
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
59 |
| 6511 |
Apheresis |
Allogeneic
|
Other Myelodysplastic Syndromes
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
67 |
| 6512 |
Apheresis |
Allogeneic
|
Other Myelofibrosis
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
57 |
| 6513 |
Apheresis |
Allogeneic
|
Peripheral T-Cell Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
50 |
| 6514 |
Apheresis |
Allogeneic
|
Plasma Cell Disorder
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
64 |
| 6515 |
Apheresis |
Allogeneic
|
Plasma Cell Disorder
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
57 |
| 6516 |
Apheresis |
Autologous
|
Plasma Cell Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
52 |
| 6517 |
Apheresis |
Allogeneic
|
Post-Essential Thrombocythemia-Myelofibrosis
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
53 |
| 6518 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
67 |
| 6519 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
69 |
| 6520 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
66 |
| 6521 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma Relapse
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
63 |
| 6522 |
Apheresis |
Allogeneic
|
Primary Immunodeficiency
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
3 |
| 6523 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis; Secondary Acute Myelogenous Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
53 |
| 6524 |
Apheresis |
Allogeneic
|
Prolymphocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
62 |
| 6525 |
Apheresis |
Autologous
|
Refractory Diffuse Large B-Cell Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
36 |
| 6526 |
Apheresis |
Allogeneic
|
Refractory Diffuse Large B-Cell Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
50 |
| 6527 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
58 |
| 6528 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
68 |
| 6529 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia At Primary Myelofibrosis
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
56 |
| 6530 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
18 |
| 6531 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
74 |
| 6532 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
24 |
| 6533 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
70 |
| 6534 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
6 |
| 6535 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
13 |
| 6536 |
Apheresis |
Allogeneic
|
Severe Combined Immunodeficiency
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
2 |
| 6537 |
Apheresis |
Allogeneic
|
T-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
7 |
| 6538 |
Apheresis |
Allogeneic
|
T-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
13 |
| 6539 |
Apheresis |
Allogeneic
|
T-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
45 |
| 6540 |
Apheresis |
Allogeneic
|
T-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
40 |
| 6541 |
Apheresis |
Autologous
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
67 |
| 6542 |
Apheresis |
Autologous
|
T-Cell-Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
67 |
| 6543 |
Apheresis |
Allogeneic
|
T-Cell-Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
23 |
| 6544 |
Apheresis |
Allogeneic
|
Thalassemia Major
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
5 |
| 6545 |
Apheresis |
Allogeneic
|
Therapy-Related Myelodysplastic Syndromes
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
65 |
| 6546 |
Adipose Tissue |
Autologous
|
Condition After Injury Of The Left Knee Joint
|
Orthopedy
|
2018
|
Experimental Therapy
|
Poland
|
33 |
| 6547 |
Adipose Tissue |
Autologous
|
Coxarthrosis
|
Orthopedy
|
2018
|
Experimental Therapy
|
Poland
|
53 |
| 6548 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6549 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6550 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6551 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6552 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6553 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6554 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6555 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6556 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2018
|
Experimental Therapy
|
Poland
|
69 |
| 6557 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2018
|
Experimental Therapy
|
Poland
|
42 |
| 6558 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6559 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6560 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6561 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6562 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6563 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6564 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6565 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6566 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6567 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6568 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2018
|
Clinical Trial
|
Poland
|
0 |
| 6569 |
Cord Tissue |
Allogeneic – Unrelated
|
Limb-Girdle Muscular Dystrophy
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
44 |
| 6570 |
Cord Tissue |
Allogeneic – Unrelated
|
Limb-Girdle Muscular Dystrophy
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
25 |
| 6571 |
Cord Tissue |
Allogeneic – Unrelated
|
Limb-Girdle Muscular Dystrophy
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
38 |
| 6572 |
Cord Tissue |
Allogeneic – Unrelated
|
Limb-Girdle Muscular Dystrophy
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
26 |
| 6573 |
Cord Tissue |
Allogeneic – Unrelated
|
Limb-Girdle Muscular Dystrophy
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
37 |
| 6574 |
Cord Tissue |
Allogeneic – Unrelated
|
Limb-Girdle Muscular Dystrophy
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
62 |
| 6575 |
Cord Tissue |
Allogeneic – Unrelated
|
Limb-Girdle Muscular Dystrophy
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
35 |
| 6576 |
Cord Tissue |
Allogeneic – Unrelated
|
Limb-Girdle Muscular Dystrophy
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
31 |
| 6577 |
Cord Tissue |
Allogeneic – Unrelated
|
Acute Graft Versus Host Disease
|
Hematology
|
2017
|
Experimental Therapy
|
Poland
|
13 |
| 6578 |
Cord Tissue |
Allogeneic – Unrelated
|
Acute Graft Versus Host Disease
|
Hematology
|
2017
|
Experimental Therapy
|
Poland
|
11 |
| 6579 |
Cord Tissue |
Allogeneic – Unrelated
|
Acute Graft Versus Host Disease
|
Hematology
|
2017
|
Experimental Therapy
|
Poland
|
2 |
| 6580 |
Cord Tissue |
Allogeneic – Unrelated
|
Acute Graft Versus Host Disease
|
Hematology
|
2017
|
Experimental Therapy
|
Poland
|
8 |
| 6581 |
Cord Tissue |
Allogeneic – Unrelated
|
Acute Graft Versus Host Disease
|
Hematology
|
2017
|
Experimental Therapy
|
Poland
|
7 |
| 6582 |
Cord Tissue |
Allogeneic – Unrelated
|
Age-Related Macular Degeneration
|
Ophthalmology
|
2017
|
Experimental Therapy
|
Poland
|
33 |
| 6583 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
67 |
| 6584 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
37 |
| 6585 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
71 |
| 6586 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
0 |
| 6587 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
47 |
| 6588 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
56 |
| 6589 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
48 |
| 6590 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
46 |
| 6591 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
45 |
| 6592 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
75 |
| 6593 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
51 |
| 6594 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
59 |
| 6595 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
64 |
| 6596 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
56 |
| 6597 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
40 |
| 6598 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
69 |
| 6599 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
52 |
| 6600 |
Cord Tissue |
Allogeneic – Unrelated
|
Amyotrophic Lateral Sclerosis
|
Neurology
|
2017
|
Experimental Therapy
|
Poland
|
35 |